Marshall William Stuart 4
4 · MIRAGEN THERAPEUTICS, INC. · Filed Feb 15, 2018
Insider Transaction Report
Form 4
Marshall William Stuart
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2018-02-13−115,818→ 0 totalExercise: $0.57Exp: 2018-07-30→ Common Stock (115,818 underlying) - Exercise/Conversion
Common Stock
2018-02-13$0.57/sh+115,818$66,016→ 265,646 total
Footnotes (2)
- [F1]This filing relates to the exercise of vested options to purchase the Issuer's common stock granted to the Reporting Person under one of the Issuer's equity incentive plans. None of the shares of common stock received upon exercise of the option were sold by the Reporting Person and all such shares are subject to a lock-up agreement between the Reporting Person and certain underwriters.
- [F2]The option is fully vested and exercisable. The option expires ten years after the date of grant.